Association Between Antipsychotic Medication Use and Diabetes

Area of Science:

• Endocrinology
• Psychiatry
• Epidemiology

Background:

• Diabetes prevalence is 2-3 times higher in severe mental illness (SMI) populations compared to the general population.
• Concerns exist regarding antipsychotic medications exacerbating diabetes risk in SMI patients.

Purpose of the Study:

• To review current epidemiological data on the link between antipsychotics and diabetes.
• To explore the mechanisms by which antipsychotics may cause diabetes.
• To discuss clinical strategies for minimizing metabolic health impacts.

Main Methods:

• Review of recent epidemiological studies.
• Examination of proposed biological mechanisms.
• Analysis of clinical implications and management strategies.

Main Results:

• Antipsychotic use is associated with a rapid increase in diabetes prevalence, particularly after initiation.
• Mechanisms include medication-induced weight gain and direct adverse effects on insulin sensitivity and secretion.
• Effective diabetes prevention, screening, and management are essential in this population.

Conclusions:

• Antipsychotics pose a significant risk for developing diabetes in individuals with severe mental illness.
• Further research is needed to elucidate causal pathways and optimize clinical care.
• Integrated approaches to mental and metabolic health are paramount.